| Not Yet Recruiting | Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies Follicular Lymphoma | — | 2026-06-01 |
| Not Yet Recruiting | A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangi Primary Sclerosing Cholangitis | Phase 3 | 2026-04-30 |
| Not Yet Recruiting | Retrospective Observational Study of Odevixibat Outcomes in Patients With PFIC Versus an External Control Coho PFIC - Progressive Familial Intrahepatic Cholestasis | — | 2026-04-01 |
| Recruiting | A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Line Moderate to Severe Glabellar Lines | Phase 3 | 2026-02-27 |
| Recruiting | A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle Moderate to Severe Glabellar Lines | Phase 3 | 2026-02-18 |
| Not Yet Recruiting | A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain Tumours Low-grade Glioma | Phase 1 | 2026-02-16 |
| Recruiting | A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 / Phase 2 | 2026-02-06 |
| Recruiting | Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment Neuroendocrine Tumors | — | 2025-12-17 |
| Recruiting | A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrahepatic Cho PFIC - Progressive Familial Intrahepatic Cholestasis | — | 2025-12-08 |
| Recruiting | A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Ac Locally Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 / Phase 2 | 2025-12-05 |
| Recruiting | A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intr Progressive Familial Intrahepatic Cholestasis | — | 2025-10-30 |
| Completed | A Study Describing Scratch and Sleep Patterns in Patients With Primary Biliary Cholangitis (Luminaria) Primary Biliary Cholangitis | — | 2025-07-16 |
| Recruiting | A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults Cervical Dystonia | Phase 2 | 2025-06-30 |
| Recruiting | A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syn Alagille Syndrome | — | 2025-04-22 |
| Recruiting | A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours Advanced Solid Tumor | Phase 1 / Phase 2 | 2025-03-14 |
| Completed | A Study of the Blood Levels of Palovarotene in Participants With Abnormal Liver Function Compared to Healthy A Hepatic Impairment, Healthy | Phase 1 | 2025-03-14 |
| Active Not Recruiting | A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC) Primary Biliary Cholangitis | Phase 3 | 2025-01-16 |
| Recruiting | A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants Fibrodysplasia Ossificans Progressiva | — | 2024-12-05 |
| Terminated | Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma Osteosarcoma, Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults | Phase 2 | 2024-11-22 |
| Recruiting | A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Bilia Primary Biliary Cholangitis | — | 2024-10-14 |
| Recruiting | A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults Episodic Migraine, Chronic Migraine | Phase 2 | 2024-10-10 |
| Active Not Recruiting | A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ur Primary Biliary Cholangitis | Phase 3 | 2024-07-09 |
| Completed | A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) an Gastro-enteropancreatic Neuroendocrine Tumor, Acromegaly | — | 2024-05-29 |
| Recruiting | A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours Melanoma, Head and Neck Squamous Cell Carcinoma, Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | 2024-04-03 |
| Active Not Recruiting | CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated W Upper Limb Injury | — | 2023-11-16 |
| Active Not Recruiting | A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Wa Spasticity as Sequela of Stroke | — | 2023-11-01 |
| Active Not Recruiting | A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults Chronic Migraine | Phase 3 | 2023-10-12 |
| Active Not Recruiting | A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults Episodic Migraine | Phase 3 | 2023-09-29 |
| Recruiting | Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During P Pregnancy Related | — | 2023-09-28 |
| Recruiting | A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis Primary Biliary Cholangitis (PBC) | Phase 3 | 2023-08-31 |
| Terminated | A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (N Neuroendocrine Tumors | — | 2023-06-15 |
| Completed | A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin For Prostate Cancer | — | 2023-04-24 |
| Withdrawn | Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in Chin Acromegaly | — | 2023-02-13 |
| Active Not Recruiting | A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholan Primary Sclerosing Cholangitis | Phase 2 | 2022-12-29 |
| Completed | Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Pr Advanced Prostate Cancer, Metastatic Prostate Cancer, Locally Advanced Prostate Cancer | Phase 3 | 2022-11-17 |
| Completed | A Study to Evaluate the Effect of Food on the Level of Circulating Elafibranor in Healthy Participants After I Healthy Participants | Phase 1 | 2022-10-27 |
| Active Not Recruiting | A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Advanced Renal Cell Carcinoma | — | 2022-09-26 |
| Completed | A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Spastic Hemiparesis, Muscle Spasticity | — | 2022-09-20 |
| Completed | Study to Compare the Level of Elafibranor in Blood After Repeat Administration in Japanese and Non-Asian Healt Healthy Volunteers | Phase 1 | 2022-09-19 |
| Completed | A Study to Collect Pre-existing Data on the Administration of Cabozantinib in Participants With Advanced Renal Advanced Renal Cell Carcinoma | — | 2022-09-16 |
| Completed | Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate Prostate Cancer | Phase 3 | 2022-08-30 |
| Completed | Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China Acromegaly | — | 2022-06-30 |
| Active Not Recruiting | Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving T Early-stage Breast Cancer | — | 2022-06-09 |
| Completed | A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Metastatic Pancreatic Adenocarcinoma | Phase 1 | 2022-05-30 |
| Completed | Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A Post-Stroke Chronic Upper Limb Spasticity | — | 2022-05-09 |
| Completed | A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Parti Fibrodysplasia Ossificans Progressiva (FOP) | Phase 3 | 2022-03-14 |
| Completed | A Single Centre, Prospective, Observational Study to Assess the Use of the Rehabilitation Tool, GripAble, in P Upper Limb Spasticity (ULS) | — | 2022-03-02 |
| Completed | Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing Combination Advanced Renal Cell Carcinoma (aRCC) | — | 2021-09-09 |
| Completed | A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants Wi Central Precocious Puberty | Phase 3 | 2021-08-10 |
| Completed | A Comparative Study to Evaluate the Effects and Mechanism of Action of Dysport®, Botox® and Xeomin® in the Ext Healthy Participants | Phase 1 | 2021-07-06 |
| Completed | A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity. Upper Limb Spasticity | Phase 4 | 2021-06-23 |
| Completed | Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs Gastroenteropancreatic Neuroendocrine Tumor | Phase 3 | 2021-05-24 |
| Recruiting | A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity. Spasticity | Phase 1 / Phase 2 | 2021-04-29 |
| Completed | United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting Neuroendocrine Tumours (NET) | — | 2021-04-27 |
| Recruiting | A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Faci Moderate to Severe Upper Facial Lines | Phase 1 / Phase 2 | 2021-04-06 |
| Completed | Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puber Central Precocious Puberty | Phase 3 | 2021-03-27 |
| Withdrawn | Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patien Pancreatic Ductal Adenocarcinoma, Colorectal Cancer | Phase 1 | 2021-03-12 |
| Completed | Retrospective Real-Life Study From One Brazilian Reference Center Assessing Long-Term Experience In The Treatm Spasticity | — | 2021-03-05 |
| Terminated | Study to Evaluate the Safety and Efficacy of IPN59011 in Improving the Appearance of Moderate to Severe Upper Moderate Upper Facial Lines, Severe Upper Facial Lines | Phase 1 | 2021-02-10 |
| Completed | A Study to Review Treatment Outcomes From Treatment With Dysport® Injections in Adults for Upper and/or Lower Upper and/or Lower Limb Focal Spasticity | — | 2021-02-04 |
| Completed | An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) Fibrodysplasia Ossificans Progressiva | — | 2021-01-18 |
| Completed | A Study to Assess Treatment Outcomes of abobotulinumtoxinA and onabotulinumtoxinA Treatments in Real Life Prac Spasticity Related to Any Cause Except Cerebral Palsy | — | 2021-01-11 |
| Completed | Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treat Prostate Cancer | — | 2020-11-30 |
| Completed | Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England Renal Cell Carcinoma | — | 2020-11-24 |
| Withdrawn | Study on the Utilization of Cabozantinib in Adult Patients With Advanced or Metastatic Renal Cell Carcinoma (R Renal Cell Carcinoma | — | 2020-11-06 |
| Active Not Recruiting | Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) Primary Biliary Cirrhosis | Phase 3 | 2020-09-24 |
| Completed | Study Assessing Adult Subjects Affected With Upper and/or Lower Limb Spasticity Treated With Botulinum Neuroto Spasticity | — | 2020-07-21 |
| Completed | Relation Between Dose and Time to Reinjection of Botulinum Toxin-A in Patient With Poststroke Spasticity From Post Stroke Spasticity | — | 2020-04-29 |
| Withdrawn | Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly Acromegaly | — | 2020-04-01 |
| Active Not Recruiting | Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Rena Advanced or Metastatic Renal Cell Carcinoma | — | 2020-03-03 |
| Completed | A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plu Metastatic Adenocarcinoma of the Pancreas | Phase 3 | 2020-02-11 |
| Completed | Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carci Locally Advanced or Metastatic Renal Cell Carcinoma | — | 2020-01-30 |
| Completed | Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcino Locally Advanced or Metastatic Renal Cell Carcinoma | Phase 2 | 2020-01-08 |
| Completed | Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohor Adult Lower Limb Spasticity | — | 2019-12-19 |
| Withdrawn | Study to Assess the Use of Lanreotide Autogel® 120 mg in Patients With Locally Advanced or Metastatic Gastroen Neuroendocrine Tumors | — | 2019-08-01 |
| Completed | Spasticity and Treatment Satisfaction Among Stroke Survivors Spasticity as Sequela of Stroke | — | 2019-07-20 |
| Terminated | Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Pancreatic Neuroendocrine Tumor | — | 2019-07-03 |
| Completed | Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients Renal Cell Carcinoma, Hepatocellular Carcinoma, Differentiated Thyroid Carcinoma | — | 2019-05-15 |
| Terminated | Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Ima Small Cell Lung Cancer and Breast Cancer | Phase 1 / Phase 2 | 2019-05-14 |
| Terminated | Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours Solid Tumor | Phase 1 | 2019-03-22 |
| Completed | Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC Renal Cell Carcinoma Metastatic, Renal Cell Carcinoma | — | 2019-02-22 |
| Completed | Validation of Patient Reported Outcome Measures for Use in Vulvodynia Vulvodynia | — | 2019-02-18 |
| Completed | A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients W Advanced Renal Cell Carcinoma | — | 2018-12-20 |
| Completed | Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interv Renal Cell Carcinoma | — | 2018-11-06 |
| Completed | Validation of Patient Reported Outcome Measures for Use in Hallux Valgus Hallux Valgus | — | 2018-10-30 |
| Completed | Dysport in Post-Surgical Neuralgia Chronic Scar Pain | Phase 2 | 2018-10-30 |
| Terminated | Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent Breast Cancer | Phase 2 | 2018-10-22 |
| Active Not Recruiting | Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma | — | 2018-09-24 |
| Completed | Perception of Information and Quality of Life in Neuroendocrine Tumour on Lanreotide Autogel Neuroendocrine Tumors | — | 2018-07-20 |
| Completed | Efficacy, Safety and Tolerability of a New Bowel Cleansing Preparation (BLI800) in Adult Subjects Undergoing C Diagnosis Disease | Phase 3 | 2018-07-01 |
| Completed | Dysport in Hallux Abducto Valgus (HAV) Phase IIa Hallux Abducto Valgus | Phase 2 | 2018-06-19 |
| Terminated | Dysport in Vulvodynia Phase II Study Vulvodynia | Phase 2 | 2018-06-11 |
| Completed | Validation of the Spasticity Related Quality of Life Questionnaire Spasticity, Muscle | N/A | 2018-05-25 |
| Terminated | Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tum Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Gastric Cancer | Phase 1 | 2018-05-03 |
| Completed | Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer Small Cell Lung Cancer | Phase 3 | 2018-04-25 |
| Completed | Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma Renal Cell Carcinoma | — | 2018-04-24 |
| Completed | Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years In Prostate Cancer | — | 2018-03-09 |
| Completed | Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With N Renal Impairment | Phase 1 | 2018-02-09 |
| Completed | Efficacy, Safety and Tolerability of Eziclen®/Izinova® Versus Klean-prep® on Bowel Cleansing in Adolescents Un Digestive System Disease | Phase 3 | 2017-10-15 |
| Completed | To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects Gastro-Enteropancreatic Neuroendocrine Tumor | Phase 2 | 2017-09-26 |
| Completed | Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin ( Endometriosis | Phase 3 | 2017-07-28 |
| Completed | Study to Evaluate the Use of Resources and the Costs Associated With Carcinoid Syndrome (CS) in Patients With Neuroendocrine Tumors | — | 2017-07-21 |
| Completed | To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Pro Prostate Cancer | — | 2017-07-13 |
| Completed | Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroend Gastroenteropancreatic Neuroendocrine Tumor | — | 2017-04-12 |
| Completed | Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors Neuroendocrine Tumors | — | 2017-04-04 |
| Terminated | Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumou Neuroendocrine Tumors in Lung | Phase 3 | 2017-03-06 |
| Terminated | Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs Neuroendocrine Tumors | Phase 1 / Phase 2 | 2017-03-06 |
| Completed | Effectiveness and Safety of Dysport® (abobotulinumtoxinA) in Paediatric Lower Limb Spasticity Lower Limb Spasticity | — | 2017-02-10 |
| Terminated | Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly Acromegaly | Phase 2 | 2017-01-26 |
| Completed | Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitatio Spastic Hemiparesis | Phase 4 | 2016-12-18 |
| Completed | Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea Chronic Functional Diarrhea of Unknown Origin | Phase 1 | 2016-08-01 |
| Terminated | Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due Urinary Incontinence, Overactive Bladder | Phase 3 | 2016-07-08 |
| Completed | Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neu Neuroendocrine Tumours | Phase 2 | 2016-07-01 |
| Completed | Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects Acromegaly | — | 2016-07-01 |
| Terminated | A Retrospective Data Analysis of Therapy With PRRT Combined With Lanreotide Autogel® for Neuroendocrine Tumour Neuroendocrine Tumours | — | 2016-06-01 |
| Completed | Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tu Gastrointestinal Neuroendocrine Tumours | — | 2016-04-01 |
| Completed | Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults Acute Diarrhoea | Phase 4 | 2016-03-17 |
| Completed | Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastr Gastroenteropancreatic Neuroendocrine Tumours | — | 2016-03-01 |
| Terminated | Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due Urinary Incontinence, Overactive Bladder | Phase 3 | 2016-03-01 |
| Completed | Study to Evaluate a Dose of Telotristat Etiprate in Male and Female With Mild, Moderate and Severe Hepatic Ins Hepatic Impairment | Phase 1 | 2016-02-01 |
| Terminated | Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg Acromegaly | — | 2016-01-01 |
| Completed | Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically Whil Pancreatic Tumours, Midgut Neuroendocrine Tumours | Phase 2 | 2015-12-15 |
| Completed | Community-based Neuroendocrine Tumor (NET) Research Study Gastroenteropancreatic Neuroendocrine Tumors | — | 2015-11-23 |
| Completed | Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Pati Pancreatic Cancer | Phase 2 | 2015-10-19 |
| Completed | Eziclen Drug Utilisation in Real Life Setting Bowel Cleansing | — | 2015-10-01 |
| Completed | Perception of Cohesion Within a Relationship (Dyadic Adjustment) on the Quality of Life of Patients With Prost Prostate Cancer | — | 2015-10-01 |
| Completed | Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Prostate Cancer | — | 2015-07-01 |
| Completed | Validation Study of the SAGIT® Instrument in Acromegaly Acromegaly | — | 2015-07-01 |
| Completed | Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients Spasticity | — | 2015-06-01 |
| Completed | Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabell Glabellar Lines | Phase 3 | 2015-04-01 |
| Completed | Dysport in the Treatment of Glabellar Lines in Chinese Subjects Glabellar Lines | Phase 3 | 2015-04-01 |
| Completed | Study to Document the Effectiveness of Dysport in Patients Suffering From Upper Limb Spasticity (ULS) After St Post Stroke Arm Spasticity | — | 2015-03-01 |
| Completed | Efficacy, Safety and Tolerability of Eziclen in Adult Subjects Undergoing Colonoscopy Bowel Cleansing | Phase 3 | 2015-03-01 |
| Completed | Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonge Acromegaly | Phase 1 / Phase 2 | 2015-03-01 |
| Terminated | Quality of Life in Patients With Inoperable Malignant Bowel Obstruction Intestinal Obstruction | Phase 2 | 2015-01-01 |
| Completed | Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabella Moderate to Severe Glabellar Lines | Phase 3 | 2015-01-01 |
| Completed | Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Prac Upper Limb Spasticity | — | 2015-01-01 |
| Completed | Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression Stroke, Upper Limb Spasticity | Phase 4 | 2014-12-01 |
| Completed | Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment. Acromegaly | — | 2014-12-01 |
| Completed | Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated Intestinal Obstruction | Phase 2 | 2014-11-19 |
| Completed | Botulinum Toxin A Associated Costs in the Treatment of Upper Limb Spasticity Post Stroke Upper Limb Spasticity Post-Stroke | — | 2014-11-01 |
| Completed | Patient and Physician's Satisfaction After a Long Term Treatment of Glabellar Lines With Dysport® Glabellar Lines | — | 2014-10-01 |
| Completed | Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET Gastroenteropancreatic Neuroendocrine Tumors | Phase 2 | 2014-10-01 |
| Completed | Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Ac Acromegaly | Phase 3 | 2014-10-01 |
| Terminated | Study Exploring Safety, Pharmacokinetic and Pharmacodynamic of BN82451 in Male Huntington's Disease Patients Huntington's Disease | Phase 2 | 2014-09-01 |
| Terminated | Predictive Factors Study Acromegaly | — | 2014-08-01 |
| Completed | ETREAT Study on Effectiveness of Botulinum Toxin Type A Injections to Treat Post-stroke Upper and/or Lower Lim Spasticity | — | 2014-07-01 |
| Completed | The Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over Insomnia | — | 2014-06-01 |
| Completed | EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Cognitive Disorders | — | 2014-06-01 |
| Completed | 68Ga-OPS202 Study for Diagnostic Imaging of GEP NET Gastroenteropancreatic Neuroendocrine Tumors | Phase 1 / Phase 2 | 2014-06-01 |
| Completed | Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients NeuroEndocrine Tumours | Phase 4 | 2014-05-01 |
| Completed | RELIEF Study: Lower Limb Pain Relief After Injection Cycles in Adults Suffering From Lower Limb Spasticity Fol Lower Limb Spasticity | — | 2014-04-01 |
| Completed | Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In Children Upper Limb Spasticity (Altered Skeletal Muscle Performance) in Children | Phase 3 | 2014-04-01 |
| Completed | Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs Gastroenteropancreatic Neuroendocrine Tumors | — | 2014-03-24 |
| Terminated | Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate Cancer Prostatic Neoplasms, Castration-Resistant | Phase 3 | 2014-01-01 |
| Completed | Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer Prostate Cancer | — | 2014-01-01 |
| Completed | Programme of Acromegaly Screening in Patients With Associated Somatic Disorders Acromegaly | — | 2013-12-05 |
| Completed | Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer Prostate Cancer | — | 2013-11-01 |
| Completed | A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometrio Deep Infiltrating Endometriosis (DIE) | — | 2013-09-16 |
| Completed | Description of Sign-and-symptom Associations at Acromegaly Diagnosis. Acromegaly | — | 2013-09-01 |
| Completed | Study To Optimize Photodynamic Transurethral Resection of the Bladder (TUR-B) In Clinical Practice Photodynamic Transurethral Resection of the Bladder (TUR-B) | — | 2013-07-01 |
| Withdrawn | Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Idiopathic Short Stature | Phase 4 | 2013-05-01 |
| Completed | Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcera Ulcerative Colitis | — | 2013-04-24 |
| Completed | Arm Spasticity - Non-Interventional Study Early BIRD (BoNT Treatment: Initial and Repeated Documentation) Post-stroke Arm Spasticity | — | 2013-03-01 |
| Completed | Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia Cervical Dystonia | Phase 3 | 2013-03-01 |
| Completed | SAGIT for Classification of Patients With Acromegaly in Clinical Practice Acromegaly | — | 2013-02-01 |
| Terminated | A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistan Metastatic Castrate Resistant Prostate Cancer | Phase 2 | 2013-01-01 |
| Completed | Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer | Phase 3 | 2013-01-01 |
| Completed | Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia. Cervical Dystonia | Phase 3 | 2013-01-01 |
| Completed | A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance Af Prostate Cancer | Phase 4 | 2012-12-11 |
| Completed | Phase IV-Cervical Dystonia-INTEREST IN CD2 Cervical Dystonia | — | 2012-12-01 |
| Completed | A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers Advanced or Metastatic Hepatocellular Cancer, Advanced or Metastatic Ovarian Cancer, Metastatic Renal Cell Cancer | Phase 2 | 2012-12-01 |
| Completed | MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of F Solid Tumors, ER/PR Positive Breast Cancer, Triple Negative Breast Cancer | Phase 1 | 2012-11-01 |
| Terminated | Comparing Lower-concentration Dysport Treatment Targeted to the Neuromuscular Junction With Current Clinical P Arm Spasticity | Phase 3 | 2012-09-01 |
| Terminated | GP Extended Action Triptorelin Prostate Cancer | Phase 4 | 2012-08-01 |
| Terminated | IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population IGF-1 Deficiency | — | 2012-07-01 |
| Completed | Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients Suffering Cervical Dystonia | — | 2012-07-01 |
| Completed | Somatuline Predictive Factors in Acromegaly and NET Acromegaly, Neuroendocrine Tumours | — | 2012-06-01 |
| Completed | Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant State Prostate Cancer | — | 2012-04-01 |
| Terminated | Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate C Prostate Cancer | Phase 2 | 2012-03-01 |
| Completed | One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With Macroadenoma Acromegaly | — | 2012-01-01 |
| Completed | Study of Diphereline 3.75 mg Treatment In Women Suffering From Internal Genital Endometriosis Internal Endometriosis | — | 2011-11-03 |
| Terminated | Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Pat Prostate Cancer | Phase 2 | 2011-11-01 |
| Completed | Dysport® Adult Upper Limb Spasticity Extension Study Nervous System Disorders | Phase 3 | 2011-11-01 |
| Completed | A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer Advanced Prostate Cancer | — | 2011-10-01 |
| Completed | Dysport® Pediatric Lower Limb Spasticity Follow-on Study Cerebral Palsy, Muscle Spasticity, Children | Phase 3 | 2011-10-01 |
| Completed | Adult Subjects Suffering From Lower Limb Spasticity Following Stroke Spasticity | — | 2011-09-01 |
| Completed | Dysport® Adult Upper Limb Spasticity Nervous System Disorders | Phase 3 | 2011-08-01 |
| Completed | Dysport® Pediatric Lower Limb Spasticity Study Cerebral Palsy, Muscle Spasticity, Children | Phase 3 | 2011-07-01 |
| Terminated | Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients Prostate Cancer | Phase 3 | 2011-06-01 |
| Completed | Dysport® Adult Lower Limb Spasticity Follow-on Study Post-stroke Spasticity, Spasticity Post-Traumatic Brain Injury | Phase 3 | 2011-06-01 |
| Completed | A Study of the Potential Risk Factors Linked to the Development of Severe Forms of Endometriosis Endometriosis | — | 2011-05-01 |
| Terminated | Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal W Breast Cancer | Phase 2 | 2011-05-01 |
| Completed | Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis Detrusor Muscle Hyperactivity | Phase 2 | 2011-05-01 |
| Completed | Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Cervical Dystonia | Phase 3 | 2011-04-01 |
| Completed | DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia Cervical Dystonia | — | 2011-04-01 |
| Completed | Safety and Efficacy Study of Dysport RU and Glabellar Lines Glabellar Frown Lines | Phase 2 | 2011-03-01 |
| Completed | Dysport® Adult Lower Limb Spasticity Study Leg Spasticity | Phase 3 | 2011-03-01 |
| Completed | Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg Prostate Cancer | Phase 2 | 2010-12-01 |
| Terminated | A Prospective, Non-interventional Survey to Evaluate Injection Intervals and Treatment Modalities of Botulinum Upper Limb Spasticity After Stroke | — | 2010-12-01 |
| Terminated | Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy Endometrial Cancer | Phase 2 | 2010-11-01 |
| Completed | A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Neuroendocrine Tumors, Carcinoid Syndrome | — | 2010-10-01 |
| Completed | Study in Polish Acromegalic Patients Treated With Somatuline Autogel Acromegaly | — | 2010-10-01 |
| Terminated | Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome Carcinoid Syndrome | Phase 2 | 2010-02-01 |
| Completed | To Document the Effectiveness of BoNT-A Injection in Adult Subjects With Upper Limb Spasticity Following Strok Muscle Spasticity | — | 2010-01-01 |
| Completed | Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer Prostate Cancer | Phase 3 | 2009-11-01 |
| Terminated | Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With Acromegaly Acromegaly | Phase 2 | 2009-10-01 |
| Completed | The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Endometrial Cancer | Phase 2 | 2009-08-01 |
| Completed | Lanreotide Autogel in the Symptomatic Treatment of Refractory Diarrhea Diarrhea | Phase 2 / Phase 3 | 2009-07-01 |
| Completed | An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome Carcinoid Syndrome | Phase 3 | 2009-05-01 |
| Completed | Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour Non Functioning Entero-pancreatic Endocrine Tumour | Phase 3 | 2009-02-01 |
| Completed | Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical Dyst Idiopathic Cervical Dystonia | — | 2009-02-01 |
| Completed | BN83495 in Prostate Cancer Prostate Cancer | Phase 1 | 2009-01-01 |
| Completed | Non Interventional Post Marketing Programme in Neuroendocrine Tumours Neuroendocrine Tumors | — | 2008-12-01 |
| Completed | Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic S Acromegaly | Phase 4 | 2008-10-01 |
| Completed | Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions Alzheimer's Disease, Cognitive Impairment | Phase 2 | 2008-10-01 |
| Completed | Epidemiology Study on Insulin-like Growth Factor-1 in Children With Idiopathic Short Stature (EPIGROW Study) Idiopathic Short Stature | — | 2008-10-01 |
| Completed | Non Interventional Post Marketing Programme in Acromegaly Acromegaly | — | 2008-07-01 |
| Completed | Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia Friedreich Ataxia | Phase 2 | 2008-06-01 |
| Completed | Somatuline Autogel Preference and Health Economy Study Neuroendocrine Tumour With Carcinoid Symptoms | Phase 4 | 2008-06-01 |
| Withdrawn | Study to Evaluate Patients With Acromegaly Treated With Lanreotide Autogel (Somatuline ATG) Acromegaly | Phase 2 | 2008-05-01 |
| Completed | Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study Acromegaly | — | 2008-05-01 |
| Completed | Lanreotide as Primary Treatment for Acromegalic Patients With Pituitary Gland Macroadenoma Acromegaly | Phase 3 | 2008-05-01 |
| Completed | Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study Precocious Puberty | Phase 3 | 2008-04-01 |
| Terminated | Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idi Overactive Bladder | Phase 2 | 2008-02-01 |
| Terminated | rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency Insulin-like Growth Factor-1 Deficiency | Phase 2 | 2007-12-01 |
| Completed | Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty Precocious Puberty | Phase 3 | 2007-10-01 |
| Completed | Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Follo Acromegaly | — | 2007-09-01 |
| Completed | Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment Parkinson's Disease | Phase 4 | 2007-05-01 |
| Completed | BN83495 Phase I in Post-menopausal Women Breast Cancer | Phase 1 | 2007-04-01 |
| Completed | Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel Acromegaly | Phase 3 | 2007-04-01 |
| Terminated | Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy? Cerebral Palsy | Phase 2 | 2007-03-01 |
| Terminated | Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Prostate Cancer | Phase 2 | 2007-02-01 |
| Terminated | Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Pro Prostate Cancer | Phase 3 | 2006-11-01 |
| Completed | Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients Acromegaly | Phase 3 | 2006-10-01 |
| Completed | Effectiveness of Smecta in Combination With Oral Rehydration in the Treatment of Acute Watery Diarrhoea in Inf Diarrhoea | Phase 3 | 2006-07-01 |
| Completed | A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency Growth Hormone Disorders | — | 2006-06-01 |
| Completed | Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours Endocrine Tumors | Phase 3 | 2006-06-01 |
| Completed | Effectiveness of Smecta in the Treatment of Acute Diarrhoea in Children Diarrhoea | Phase 3 | 2006-06-01 |
| Terminated | IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex Primary Insulin-like Growth Factor-1 Deficiency | — | 2006-06-01 |
| Completed | A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth Disorders Growth Hormone Disorders | — | 2006-06-01 |
| Completed | Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Neuroendocrine Tumours | Phase 2 | 2006-05-01 |
| Completed | Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia Cervical Dystonia | Phase 3 | 2006-02-01 |
| Terminated | Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment Thyroid-Associated Ophthalmopathy | Phase 2 | 2006-01-01 |
| Completed | Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial Spasm Hemifacial Spasm | Phase 3 | 2005-12-01 |
| Terminated | Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency Growth Disorders | Phase 3 | 2005-11-01 |
| Completed | Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia Cervical Dystonia | Phase 3 | 2005-10-10 |
| Completed | Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis Chronic Plantar Fasciitis | Phase 2 / Phase 3 | 2005-07-01 |
| Terminated | Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease Alzheimer Disease | Phase 2 | 2005-07-01 |
| Completed | Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Defici Insulin-Like Growth Factor-1 Deficiency, Growth Disorders | Phase 2 / Phase 3 | 2005-07-01 |
| Completed | To Determine the Effect of Forlax® Treatment in Children With Chronic Constipation Who May Also Suffer From So Chronic Constipation | Phase 3 | 2005-04-01 |
| Completed | A Study of the Combination of Electrical Stimulation and Dysport® in Myofascial Pain Syndrome. Myofascial Pain Syndromes | Phase 3 | 2005-04-01 |
| Completed | Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome Myofascial Pain Syndromes | Phase 2 | 2005-03-01 |
| Completed | Study on the Effects of Botulinum Toxin Type A on Back Muscle in Chronic Low Back Pain Low Back Pain | Phase 3 | 2005-01-01 |
| Completed | Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute Diarrhoea Episode in Adults Diarrhea | Phase 4 | 2005-01-01 |
| Completed | Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Myofascial Pain Syndromes | Phase 2 | 2005-01-01 |
| Completed | Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly Acromegaly | Phase 3 | 2005-01-01 |
| Completed | BN80927 in Patients With Advanced Malignant Solid Tumors Malignant Solid Tumour | Phase 1 | 2004-11-01 |
| Completed | Effects on Quality of Life Following Dysport Treatment in Post-stroke Spasticity of the Arm Cerebrovascular Accident, Muscle Spasticity | Phase 4 | 2004-11-01 |
| Completed | Post Marketing Surveillance Study of Dysport Blepharospasm, Hemifacial Spasm, Cervical Dystonia | — | 2004-10-01 |
| Completed | Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia Cervical Dystonia | Phase 3 | 2004-10-01 |
| Terminated | Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated W Malignant Carcinoid Syndrome | Phase 3 | 2004-07-01 |
| Completed | Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR Acromegaly | Phase 4 | 2004-06-01 |
| Completed | Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq Turner Syndrome, Renal Insufficiency, Chronic, Pituitary Diseases | Phase 3 | 2004-06-01 |
| Completed | Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet) Lateral Canthal Lines | Phase 2 | 2004-05-01 |
| Completed | Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Can Small Cell Lung Cancer | Phase 2 | 2004-03-12 |
| Completed | Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficien Growth Disorders, Insulin-Like Growth Factor-1 Deficiency | Phase 3 | 2004-03-01 |
| Completed | Somatuline Autogel: Acromegaly Self/Partner Injection Study Acromegaly | Phase 4 | 2004-02-01 |
| Completed | Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis Intestinal Obstruction, Carcinoma, Peritoneal Neoplasms | Phase 3 | 2003-09-01 |
| Completed | Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple Scle Multiple Sclerosis, Relapsing-Remitting | Phase 3 | 2003-08-26 |
| Completed | Efficacy Study of Dysport® in the Treatment of Anal Fissure. Anal Fissure | Phase 2 | 2003-06-01 |
| Completed | A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Ac Acromegaly | — | 2003-05-01 |
| Completed | Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity Muscle Spasticity, Cerebrovascular Accident | Phase 4 | 2003-02-01 |
| Completed | A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke Stroke, Acute, Neurological Impairment | Phase 3 | 2003-02-01 |
| Completed | Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis Migraine | Phase 2 | 2003-02-01 |
| Completed | Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm Blepharospasm | Phase 2 | 2003-01-01 |
| Completed | A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaint Memory Disorders, Age-Related, Retention Disorders, Cognitive | Phase 4 | 2002-02-01 |
| Completed | Efficacy and Tolerability of Lanreotide (Autogel 120 mg) in Patients With Acromegaly Acromegaly | Phase 3 | 2001-01-01 |
| Completed | Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 mg) in Acromegalic Patients Acromegaly | Phase 3 | 2000-09-01 |
| Completed | Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly Acromegaly | Phase 2 / Phase 3 | 2000-05-01 |
| Completed | Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae Digestive Fistulae | Phase 3 | 2000-04-01 |
| Completed | Study of Long-term Use of Forlax® in Elderly Patients With Chronic Constipation Constipation | Phase 4 | 1999-12-01 |
| Completed | Long-Term Treatment With rhIGF-1 in GHIS Growth Hormone Insensitivity Syndrome | Phase 2 / Phase 3 | 1991-05-20 |